aTyr Pharma, Inc.

NASDAQ:ATYR

Biotechnology

Healthcare
$0.53 +14.23%

+$0.07 today

Market cap
$52.13M
Beta
0.54
P/E (TTM)
-0.7
EPS (TTM)
-$0.71
52W Low $0.40High $7.29

Volume 1.02M

Average 2.29M

Income Statement

Follow revenue through to earnings.

Revenue

$190,000.00

FY 2025 · Annual

-19.1% YoY

Operating Income

-$77.63M

FY 2025 · Annual

Net Income

-$74.12M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue010.39M353K235K190K
Cost of Revenue1.3M1.7M001.55M
Gross Profit(1.3M)8.69M353K235K(1.36M)
Gross Margin—83.7%100.0%100.0%-717.4%
Research & Development23.26M42.81M42.29M54.37M60.22M
Selling, General & Admin10.75M12.29M12.98M13.78M17.6M
Operating Expenses32.71M55.1M55.27M68.15M76.26M
Depreciation & Amortization1.3M1.7M2.74M1.54M1.55M
EBITDA(32.47M)(43.65M)(47.66M)(62.48M)(72.57M)
EBITDA Margin—-420.3%-13500.3%-26588.1%-38192.1%
Operating Income(34.02M)(46.4M)(54.92M)(67.91M)(77.63M)
Operating Margin—-446.8%-15557.8%-28899.6%-40856.3%
Interest Income00000
Interest Expense00000
Other Income / Expenses238K1.06M4.52M3.89M3.51M
Income Before Tax(33.78M)(45.34M)(50.4M)(64.02M)(74.12M)
Pre-Tax Margin—-436.6%-14276.8%-27243.4%-39009.5%
Income Tax Expense00000
Net Income(33.77M)(45.34M)(50.39M)(64.02M)(74.12M)
Net Margin—-436.5%-14274.5%-27243.8%-39009.5%
EPS (Basic)(1.77)(1.60)(0.94)(0.86)(0.80)
EPS (Diluted)(1.77)(1.60)(0.94)(0.86)(0.80)
Weighted Avg Shares19.08M28.42M53.61M74.26M92.99M
Weighted Avg Shares (Diluted)19.08M28.42M53.61M74.26M92.99M

ATYR Earnings Waterfall · TTM

NASDAQ:ATYR · Revenue to Net Income

Key Ratios

EPS$-0.73
Gross Margin-2886.8%
Net Margin-3387.4%
P/E Ratio-2.4
P/S Ratio92.2

Analysis

$190.0K of revenue converted into -$70.0M of net income for the selected period. Gross margin is -2886.8% and net margin is -3387.4%, showing how much revenue survives after costs and taxes. EPS is $-0.73, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-8S-8 filingAug 7, 2026
8-KCurrent reportAug 7, 2026
10-QQuarterly reportAug 7, 2026
SC 13G/ASC 13G/A filingAug 6, 2026
8-KCurrent reportJul 31, 2026

How much revenue does ATYR generate?

aTyr Pharma, Inc. (ATYR) reported $190,000.00 of revenue in fiscal 2025.

Is ATYR profitable?

aTyr Pharma, Inc. (ATYR) reported -$74.12M of net income, with a net margin of -39009.5%.